» Articles » PMID: 37998161

Fabrication of an Azithromycin Sensor

Overview
Specialty Biotechnology
Date 2023 Nov 24
PMID 37998161
Authors
Affiliations
Soon will be listed here.
Abstract

Azithromycin (AZY) is a well-known top-prioritized antibiotic and is used by humans in strong concentrations. However, the side effects of the AZY antibiotic may cause some serious and significant damage to humans and the environment. Thus, there is a need to develop effective and sensitive sensors to monitor accurate concentrations of AZY. In the last decade, electrochemistry-based sensors have received enormous attention from the scientific community because of their high sensitivity, selectivity, cost-effectiveness, fast response, rapid detection response, simple fabrication, and working principle. It is important to mention that electrochemical sensors rely on the properties of electrode modifiers. Hence, the selection of electrode materials is of great significance when designing and developing efficient and robust electrochemical sensors. In this study, we fabricated an AZY sensor by utilizing a molybdenum disulfide/titanium aluminum carbide (MoS@TiAlC) composite as the electrode material. The MoS@TiAlC composite was synthesized via a simple sonication process. The synthesized MoS@TiAlC composite was characterized using a powder X-ray diffraction (XRD) method to examine the phase purity and formation of the MoS@TiAlC composite. Scanning electron microscopy (SEM) was used to study the surface morphological features of the prepared MoS@TiAlC composite, whereas energy dispersive X-ray spectroscopy (EDAX) was adopted to determine the elemental composition of the prepared MoS@TiAlC composite. The glassy carbon (GC) electrode was modified with the prepared MoS@TiAlC composite and applied as the AZY sensor. The sensing performance of the MoS@TiAlC composite-modified GC electrode was studied using linear sweep voltammetry. The sensor demonstrated excellent performance when determining AZY and showed a good detection limit of 0.009 µM with a sensitivity of 6.77 µA/µM.cm.

References
1.
Ray W, Murray K, Hall K, Arbogast P, Stein C . Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012; 366(20):1881-90. PMC: 3374857. DOI: 10.1056/NEJMoa1003833. View

2.
Wu Y, Ji X, Hu S . Studies on electrochemical oxidation of azithromycin and its interaction with bovine serum albumin. Bioelectrochemistry. 2004; 64(1):91-7. DOI: 10.1016/j.bioelechem.2004.03.005. View

3.
Zhou T, Tao Y, Jin H, Song B, Jing T, Luo D . Fabrication of a Selective and Sensitive Sensor Based on Molecularly Imprinted Polymer/Acetylene Black for the Determination of Azithromycin in Pharmaceuticals and Biological Samples. PLoS One. 2016; 11(1):e0147002. PMC: 4731201. DOI: 10.1371/journal.pone.0147002. View

4.
Tung N, Tran C, Nguyen T, Hoang T, Trinh T, Nguyen T . Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets. Eur J Pharm Biopharm. 2017; 126:187-200. DOI: 10.1016/j.ejpb.2017.03.017. View

5.
Svanstrom H, Pasternak B, Hviid A . Use of azithromycin and death from cardiovascular causes. N Engl J Med. 2013; 368(18):1704-12. DOI: 10.1056/NEJMoa1300799. View